Skip to Content


Mark Sirgo, CEO at Corium Innovations, Inc.


Chief Executive Officer

Pharmaceutical executive and entrepreneur with over thirty 35 years of industry experience from large pharma to start-up. More recently founder and CEO of BioDelivery Sciences (Nasdaq:BDSI) that went from a preclinical stage start up to a fully integrated commercial enterprise following the FDA approval of three products ending in a successful sale of the company in 2022.

Prior to BDSI, held senior positions in research and development involving ethical and over-the-counter switch products in the areas of gastrointestinal, cardiovascular, respiratory, pain and addiction at GSK. In addition, led the management of global sales and marketing for a global contract research organization (PPD). Dr. Sirgo holds a Doctorate in Pharmacy from Philadelphia College of Pharmacy and BS in Pharmacy from The Ohio State University.